30+ years of Philips innovation with MCVI – News | So Good News


Looking at today’s healthcare industry, what are the main challenges you as a physician and your hospital face, both clinical but also technological?

Dr. Katzen: The regulatory environment has definitely changed. In the early years, doctors may use some degree of trial and error when developing procedures. Now it all depends on the evidence. You must have evidence that what you are doing is better and has value for the patient. This is all very well, but it adds considerable cost and time. I think we can do much better at this, but cost is becoming a major factor among the barriers to using new solutions in the clinical environment. We’re cutting costs by being more efficient, but I think we’ve reached the limit of the value we can bring right now. It is true that minimally invasive therapies can now be performed in cheaper, more convenient out-of-hospital settings as a cost-cutting approach, but this environment itself does not necessarily support innovation because it is prohibitively expensive. The second big challenge we face is the environment in which people now work. The pandemic has had a profound effect on the healthcare environment and the people who work in it. This has made it difficult to attract people to health care and stay in care.

Bert van Meurs, as a partner How can Philips help reduce the cost of healthcare and improve the employee experience so that people want to work in healthcare and stay there?

Bert van Meurs: I think Dr. Katzen explained very well how needs have changed, and at Philips we try to reflect that in our strategy. While we used to focus a lot on image quality and clinical outcomes, today we focus on the quadruple aim, which is still about outcomes, as well as cost reduction, staff and patient experience. So it’s not just about the imaging method itself, it’s about the entire workflow of the procedure and beyond, how patients can go from diagnosis to treatment to home in a comfortable and cost-effective manner. This is where data plays a key role, meaning Philips is fast becoming an informatics player, where we use data, analyze data and use AI algorithms to help optimize workflows, focusing on the entire care pathway rather than a single episode of treatment.

Looking ahead 20, maybe 50 years from now, how do you think it will play out for a patient treated for MCVI?

Dr. Katzen: I think there will be a number of extraordinary movements in the next 20 years. One is the ability to collect real-time data using the patient as a data source, for example, sensor technology, and manage that data remotely. From an MCVI perspective, this means that we are more engaged in the ambulatory space, not only from a procedure perspective, but also from a continuity of care perspective. Patients themselves will use this data, meaning they will be more integrated and involved in their care. People will live longer, so they will get diseases that they didn’t before because they died earlier. Although a significant amount of care is moving to the outpatient space, hospitals are becoming places where more patients are treated and patients are treated. The level of sharpness increases.

Bert, would you like to respond to this and offer some final words?

Bert van Meurs: It’s hard to imagine what it will be like in 35 years. I am confident that we will continue to be a very strong partner and that we will be able to create even more and better care solutions in the next 35 years. I believe that minimally invasive surgery will become more automated, more outpatient, and more efficient, but still exists because it brings great benefits to patients and the entire health care system. I also believe that in 35 years we will be able to perform procedures without the use of X-rays, for example using smart navigation technologies, intelligent devices and robotics. This allows us to get to the lesion faster and treat it more efficiently, and provides better feedback during procedures so the patient can go home earlier, stay at home, and be monitored remotely, making the entire process more patient-friendly. . My other confidence is to continue this great partnership and collaboration with MCVI, for which we are very grateful. I am pleased to congratulate Dr. Katzen and MCVI on their 35th anniversary and look forward to the next 35 years of collaboration.


Source link